Photo by RF._.studio on Pexels
Recent research published in BMJ found that regular physical exercise appeared to bolster the efficacy of Janssen’s (NYSE:JNJ) Ad26.COV2.S COVID-19 vaccine.
While the vaccine was 60.0% effective against hospitalization in individuals with a low activity level, efficacy climbed to 85.8% for those with a high activity level. Efficacy was 72.1% for individuals in the moderate activity group.
The research defined low activity as less than 60 minutes of at least moderate-intensity weekly exercise. Moderate activity levels ranged between 61 and 149 minutes of such exercise. High activity levels required at least 150 minutes of moderate-intensity exercise.
The study authors defined moderate-level activity based on having an average heart rate between 70% and 79% of maximum.
The study used activity data from wearable devices.
Researchers assessed individual…